Doctor of Osteopathy Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Nicholas Clapper

Vascular Surgery Jackson, MS Doctor of Osteopathy

NPI 1942611314 CMS profile 10186286

2500 N State St Ste 317, Jackson, MS 39216

Open in the dashboard

General payments

$7,239

80 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Nicholas Clapper of Jackson, MS is reported in the CMS Open Payments database as having received $7,239 across 80 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 60th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,669 19
2024 General $1,254 27
2023 General $2,409 14
2022 General $330 9
2021 General $576 11

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nicholas Clapper
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Nicholas Clapper were reported at $2,669. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Nicholas Clapper Vascular Surgery median Middle half National median
2019 $0 $796 $226–$2,363 $163
2020 $0 $348 $118–$1,110 $114
2021 $576 $471 $158–$1,421 $132
2022 $330 $725 $222–$2,183 $149
2023 $2,409 $836 $257–$2,440 $160
2024 $1,254 $909 $252–$2,619 $164
2025 $2,669 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Endologix, Inc. $2,227 7 payments
  2. W. L. Gore & Associates, Inc. $1,833 15 payments
  3. AngioDynamics, Inc. $1,528 1 payment
  4. Organogenesis Inc. $408 22 payments
  5. Silk Road Medical, Inc. $292 2 payments
  6. Bard Peripheral Vascular, Inc. $219 4 payments
  7. Philips Electronics North America Corporation $183 2 payments
  8. Boston Scientific Corporation $112 4 payments
  9. Stryker Corporation $95 3 payments
  10. LeMaitre Vascular, Inc. $64 5 payments
  11. Other $279 15 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $4,653 76 payments
  2. Long term medical supply or device loan $1,528 1 payment
  3. Travel and Lodging $1,058 3 payments
Products named General payments · program years 2021–2025
  1. Alto Abdominal Stent Graft System $1,926 6 payments
  2. Auryon Laser System 100-120 Vac $1,528 1 payment
  3. GORE TAG Thoracic Endoprosthesis $782 2 payments
  4. GORE TAG Thoracic Branch Endoprosthesis $589 4 payments
  5. ENDOCROSS Device $301 1 payment
  6. Torus Stent Graft System $301 1 payment
  7. ENROUTE Transcarotid Neuroprotection System $292 2 payments
  8. ENROUTE Transcarotid Stent $292 2 payments
  9. RotarexS 6 F x 135 cm $204 3 payments
  10. GORE TAG Conformable Thoracic Endoprosthesis $195 2 payments
  11. Other $1,618 53 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

274

Median for Vascular Surgery: 122

Drug cost

$40,028

Median for Vascular Surgery: $14,135

Branded share of claims

86.5%

Median for Vascular Surgery: 71%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 36 $24,329
Xarelto Rivaroxaban Brand 18 $13,533
Clopidogrel Clopidogrel Bisulfate Brand 115 $1,435
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 68 $423
Cilostazol Generic 22 $289
Prednisone Generic 15 $19

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,087 Part D prescribers listed as Vascular Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 86 billing codes

Paid by Medicare

$343,308

Of which drugs: $359

Medicare patients

151

Average age 71

Services billed

2,857

66 women, 85 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Chronic kidney disease 60%
Diabetes 59%
Ischemic heart disease 53%
Arthritis 44%
Heart failure 39%
Depression 30%
Atrial fibrillation 27%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 30 1,890 $189
Injection, midazolam hydrochloride, per 1 mg J2250 Office 26 55 $6

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

80 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Mississippi

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record